Phibro Animal Health Corporation (PAHC)
USD 17.88
(-4.18%)
USD 17.88
(-4.18%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 458.28 Million USD | 1.27% |
| 2023 | 481.61 Million USD | 7.16% |
| 2022 | 449.43 Million USD | 9.43% |
| 2021 | 410.71 Million USD | 6.53% |
| 2020 | 385.53 Million USD | 22.92% |
| 2019 | 313.63 Million USD | 4.61% |
| 2018 | 299.8 Million USD | -2.31% |
| 2017 | 306.89 Million USD | -12.29% |
| 2016 | 349.9 Million USD | 22.04% |
| 2015 | 286.7 Million USD | 0.1% |
| 2014 | 286.42 Million USD | -21.64% |
| 2013 | 365.54 Million USD | 6.02% |
| 2012 | 344.77 Million USD | 0.0% |
| 2007 | 240.1 Million USD | 14.44% |
| 2006 | 209.8 Million USD | 18.87% |
| 2005 | 176.5 Million USD | 11.71% |
| 2004 | 158 Million USD | 54.45% |
| 2003 | 102.3 Million USD | -25.11% |
| 2002 | 136.6 Million USD | -2.08% |
| 2001 | 139.5 Million USD | -0.14% |
| 2000 | 139.7 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 480.04 Million USD | -2.15% |
| 2024 FY | 458.28 Million USD | -4.84% |
| 2024 Q3 | 456 Million USD | 1.59% |
| 2024 Q4 | 458.28 Million USD | 0.5% |
| 2024 Q1 | 487.73 Million USD | 1.36% |
| 2023 Q3 | 496.07 Million USD | 1.12% |
| 2023 Q1 | 482.02 Million USD | 7.25% |
| 2023 FY | 481.61 Million USD | 7.16% |
| 2023 Q4 | 481.61 Million USD | -2.91% |
| 2023 Q2 | 490.57 Million USD | 1.77% |
| 2022 FY | 449.43 Million USD | 9.43% |
| 2022 Q3 | 434.25 Million USD | 4.64% |
| 2022 Q4 | 449.43 Million USD | 3.5% |
| 2022 Q1 | 421.16 Million USD | 2.54% |
| 2022 Q2 | 415.01 Million USD | -1.46% |
| 2021 Q3 | 383.79 Million USD | 0.46% |
| 2021 Q4 | 410.71 Million USD | 7.01% |
| 2021 Q2 | 382.01 Million USD | -3.16% |
| 2021 FY | 410.71 Million USD | 6.53% |
| 2021 Q1 | 394.46 Million USD | 2.32% |
| 2020 FY | 385.53 Million USD | 22.92% |
| 2020 Q1 | 396.58 Million USD | 26.45% |
| 2020 Q3 | 366.21 Million USD | -2.32% |
| 2020 Q4 | 385.53 Million USD | 5.28% |
| 2020 Q2 | 374.89 Million USD | -5.47% |
| 2019 Q2 | 311.69 Million USD | -0.02% |
| 2019 Q3 | 316.66 Million USD | 1.59% |
| 2019 Q4 | 313.63 Million USD | -0.96% |
| 2019 FY | 313.63 Million USD | 4.61% |
| 2019 Q1 | 311.75 Million USD | 3.99% |
| 2018 Q1 | 323.95 Million USD | 5.56% |
| 2018 Q3 | 298.35 Million USD | -2.79% |
| 2018 Q4 | 299.8 Million USD | 0.48% |
| 2018 FY | 299.8 Million USD | -2.31% |
| 2018 Q2 | 306.91 Million USD | -5.26% |
| 2017 Q3 | 306.56 Million USD | -5.86% |
| 2017 Q4 | 306.89 Million USD | 0.11% |
| 2017 FY | 306.89 Million USD | -12.29% |
| 2017 Q1 | 339.69 Million USD | -2.92% |
| 2017 Q2 | 325.63 Million USD | -4.14% |
| 2016 Q4 | 349.9 Million USD | -3.77% |
| 2016 Q3 | 363.6 Million USD | 20.28% |
| 2016 Q1 | 303.5 Million USD | 5.86% |
| 2016 Q2 | 302.3 Million USD | -0.4% |
| 2016 FY | 349.9 Million USD | 22.04% |
| 2015 Q3 | 284.41 Million USD | -0.25% |
| 2015 FY | 286.7 Million USD | 0.1% |
| 2015 Q4 | 286.7 Million USD | 0.81% |
| 2015 Q2 | 285.11 Million USD | -0.21% |
| 2015 Q1 | 285.71 Million USD | -0.25% |
| 2014 Q4 | 286.42 Million USD | -23.5% |
| 2014 Q1 | 369.7 Million USD | 1.14% |
| 2014 FY | 286.42 Million USD | -21.64% |
| 2014 Q2 | 353.82 Million USD | -4.29% |
| 2014 Q3 | 374.39 Million USD | 5.81% |
| 2013 Q4 | 365.54 Million USD | 0.0% |
| 2013 FY | 365.54 Million USD | 6.02% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | 344.77 Million USD | 0.0% |
| 2007 FY | 240.1 Million USD | 14.44% |
| 2006 Q3 | 176.5 Million USD | -0.06% |
| 2006 FY | 209.8 Million USD | 18.87% |
| 2006 Q1 | 176.4 Million USD | -0.06% |
| 2006 Q2 | 176.6 Million USD | 0.11% |
| 2005 Q2 | 178.6 Million USD | 13.04% |
| 2005 Q1 | 158 Million USD | 0.0% |
| 2005 FY | 176.5 Million USD | 11.71% |
| 2005 Q4 | 176.5 Million USD | -0.06% |
| 2005 Q3 | 176.6 Million USD | -1.12% |
| 2004 Q1 | 102.9 Million USD | 0.59% |
| 2004 Q4 | 158 Million USD | -0.19% |
| 2004 Q3 | 158.3 Million USD | 1.21% |
| 2004 FY | 158 Million USD | 54.45% |
| 2004 Q2 | 156.4 Million USD | 51.99% |
| 2003 Q2 | 128.4 Million USD | -4.18% |
| 2003 Q1 | 134 Million USD | 0.0% |
| 2003 FY | 102.3 Million USD | -25.11% |
| 2003 Q4 | 102.3 Million USD | -0.68% |
| 2003 Q3 | 103 Million USD | -19.78% |
| 2002 FY | 136.6 Million USD | -2.08% |
| 2001 FY | 139.5 Million USD | -0.14% |
| 2000 FY | 139.7 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Journey Medical Corporation | 14.62 Million USD | -3034.243% |
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | -47.993% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | -403.194% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 10.803% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -84920.268% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -84920.268% |
| SCYNEXIS, Inc. | 12.15 Million USD | -3669.134% |
| Safety Shot Inc | 304.9 Thousand USD | -150204.519% |
| Alpha Teknova, Inc. | 13.25 Million USD | -3358.524% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 6.464% |
| Bright Green Corporation | 201.78 Thousand USD | -227019.728% |
| Dynavax Technologies Corporation | 252.41 Million USD | -81.56% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | 8.625% |
| Cosmos Health Inc. | 3.03 Million USD | -14998.435% |
| PainReform Ltd. | 30 Thousand USD | -1527530.0% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -391168.601% |
| Embecta Corp. | 1.62 Billion USD | 71.805% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | -3339.059% |
| Procaps Group, S.A. | 28.41 Million USD | -1513.126% |
| Theratechnologies Inc. | 51.26 Million USD | -794.031% |
| Harrow Health, Inc. | 183.17 Million USD | -150.196% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -526668.966% |
| Biofrontera Inc. | 804 Thousand USD | -56901.119% |
| DURECT Corporation | 2.7 Million USD | -16861.103% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | -1280.555% |
| Cronos Group Inc. | 1.55 Million USD | -29296.344% |
| OptiNose, Inc. | 611 Thousand USD | -74906.383% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 8.031% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | -1240.418% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -100622.857% |
| Organogenesis Holdings Inc. | 60.74 Million USD | -654.447% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | -3484.824% |
| Radius Health, Inc. | 339.66 Million USD | -34.924% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | -4367.625% |
| Procaps Group S.A. | 28.41 Million USD | -1513.126% |
| Alvotech | 1.02 Billion USD | 55.409% |
| TherapeuticsMD, Inc. | 6.53 Million USD | -6916.059% |
| Viatris Inc. | 16.18 Billion USD | 97.169% |
| Rockwell Medical, Inc. | 8.29 Million USD | -5426.216% |
| Aytu BioPharma, Inc. | 10.87 Million USD | -4113.377% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -136299.189% |
| Tilray Brands, Inc. | 287.93 Million USD | -59.164% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | -280.291% |
| Shineco, Inc. | 10.01 Million USD | -4474.961% |
| PetIQ, Inc. | 437.82 Million USD | -4.675% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 210 Thousand USD | -218132.857% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | -77.425% |
| Alimera Sciences, Inc. | 64.48 Million USD | -610.647% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 38.51 Million USD | -1089.928% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -339149.68% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | -6583.166% |
| Clever Leaves Holdings Inc. | 720 Thousand USD | -63551.25% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -2038189.45% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | -1298.929% |
| Hempacco Co., Inc. | 5.93 Million USD | -7627.009% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.02 Billion USD | 55.409% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | -715.229% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 25.617% |
| Currenc Group, Inc. | 2.5 Million USD | -18180.565% |
| Kamada Ltd. | 7.43 Million USD | -6061.455% |
| Indivior PLC | 235.66 Million USD | -94.465% |
| Evoke Pharma, Inc. | 5 Million USD | -9065.78% |
| Flora Growth Corp. | 942 Thousand USD | -48550.637% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -2038189.45% |
| Evolus, Inc. | 120.35 Million USD | -280.768% |
| HUTCHMED (China) Limited | 48.18 Million USD | -851.024% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 22.218% |
| Akanda Corp. | 2.49 Million USD | -18252.445% |